Effects of Shrimp Shell-Derived Chitosan on Growth, Immunity, Intestinal Morphology, and Gene Expression of Nile Tilapia (Oreochromis niloticus) Reared in a Biofloc System

Nguyen Vu Linh,Anisa Rilla Lubis,Nguyen Dinh-Hung,Supreya Wannavijit,Napatsorn Montha,Camilla Maria Fontana,Phattawin Lengkidworraphiphat,Orranee Srinual,Won-Kyo Jung,Marina Paolucci,Hien Van Doan

DOI: https://doi.org/10.3390/md22040150

2024-03-29

Marine Drugs

Abstract:Chitosan (CH) shows great potential as an immunostimulatory feed additive in aquaculture. This study evaluates the effects of varying dietary CH levels on the growth, immunity, intestinal morphology, and antioxidant status of Nile tilapia (Oreochromis niloticus) reared in a biofloc system. Tilapia fingerlings (mean weight 13.54 ± 0.05 g) were fed diets supplemented with 0 (CH0), 5 (CH5), 10 (CH10), 20 (CH20), and 40 (CH40) mL·kg−1 of CH for 8 weeks. Parameters were assessed after 4 and 8 weeks. Their final weight was not affected by CH supplementation, but CH at 10 mL·kg−1 significantly improved weight gain (WG) and specific growth rate (SGR) compared to the control (p < 0.05) at 8 weeks. Skin mucus lysozyme and peroxidase activities were lower in the chitosan-treated groups at weeks 4 and 8. Intestinal villi length and width were enhanced by 10 and 20 mL·kg−1 CH compared to the control. However, 40 mL·kg−1 CH caused detrimental impacts on the villi and muscular layer. CH supplementation, especially 5–10 mL·kg−1, increased liver and intestinal expressions of interleukin 1 (IL-1), interleukin 8 (IL-8), LPS-binding protein (LBP), glutathione reductase (GSR), glutathione peroxidase (GPX), and glutathione S-transferase (GST-α) compared to the control group. Overall, dietary CH at 10 mL·kg−1 can effectively promote growth, intestinal morphology, innate immunity, and antioxidant capacity in Nile tilapia fingerlings reared in biofloc systems.

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

This paper aims to explore the effects of chitosan derived from shrimp shells on the growth, immune function, intestinal morphology and related gene expression of Nile tilapia in the bio - floc system. Specifically, the study evaluated the effects of these additives on Nile tilapia in the following aspects by adding different concentrations of chitosan (0, 5, 10, 20 and 40 mL·kg⁻¹) to the feed:

1. **Growth performance**: The study found that the body weight gain (WG) and specific growth rate (SGR) of Nile tilapia in the 10 mL·kg⁻¹ chitosan group were significantly higher than those in the control group at 8 weeks (p < 0.05). However, the final body weight was not affected by chitosan supplementation.

2. **Immune response**:
- **Lysozyme and peroxidase activities in skin mucus**: At the 4th and 8th weeks, the lysozyme and peroxidase activities in the skin mucus of the chitosan - treated groups were lower than those in the control group (p < 0.05).
- **Lysozyme and peroxidase activities in serum**: At 4 weeks, the serum peroxidase activity in the 10 mL·kg⁻¹ chitosan group was significantly higher than that in other groups (p < 0.05), but this difference was no longer significant at 8 weeks.

3. **Intestinal morphology**: The intestinal villus length and width in the 10 and 20 mL·kg⁻¹ chitosan groups increased significantly, while the 40 mL·kg⁻¹ chitosan group had an adverse effect on the villi and muscle layers.

4. **Gene expression**:
- **Expression of immune - related genes (IL - 1, IL - 8, LBP) and antioxidant - related genes (GSR, GPX, GST - α) in the liver and intestine**: The expression of these genes in all chitosan - supplemented groups was higher than that in the control group. In particular, in the liver, the IL - 8 expression in the 5 mL·kg⁻¹ chitosan group was significantly higher than that in the control group and other dose groups (p < 0.05). In the intestine, the LBP expression in the 10 mL·kg⁻¹ chitosan group was the highest, which was significantly higher than that in the control group and other treatment groups (p < 0.05).

In conclusion, the main objective of this study was to evaluate the potential benefits of chitosan as a feed additive on the growth, immune function, intestinal morphology and gene expression of Nile tilapia in the bio - floc system, especially to determine the optimal chitosan supplementation dose. The study showed that 10 mL·kg⁻¹ of chitosan was the optimal dose, which could effectively promote the growth of Nile tilapia, enhance intestinal morphology, and improve innate immunity and antioxidant capacity.